235 related articles for article (PubMed ID: 20664535)
1. The effect of donepezil treatment on cardiovascular mortality.
Sato K; Urbano R; Yu C; Yamasaki F; Sato T; Jordan J; Robertson D; Diedrich A
Clin Pharmacol Ther; 2010 Sep; 88(3):335-8. PubMed ID: 20664535
[TBL] [Abstract][Full Text] [Related]
2. Donepezil: an update.
Seltzer B
Expert Opin Pharmacother; 2007 May; 8(7):1011-23. PubMed ID: 17472546
[TBL] [Abstract][Full Text] [Related]
3. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
4. Cardiac safety of donepezil in elderly patients with Alzheimer disease.
Isik AT; Yildiz GB; Bozoglu E; Yay A; Aydemir E
Intern Med; 2012; 51(6):575-8. PubMed ID: 22449664
[TBL] [Abstract][Full Text] [Related]
5. Switching cholinesterase inhibitor therapy in Alzheimer's disease--donepezil to rivastigmine, is it worth it?
Bullock R; Connolly C
Int J Geriatr Psychiatry; 2002 Mar; 17(3):288-9. PubMed ID: 11921158
[No Abstract] [Full Text] [Related]
6. Acetylcholinesterase inhibitors for vascular dementia and Alzheimer's disease combined with cerebrovascular disease.
Bowler JV
Stroke; 2003 Feb; 34(2):584-6. PubMed ID: 12574580
[No Abstract] [Full Text] [Related]
7. The pharmacology of donepezil: a new treatment of Alzheimer's disease.
Wilkinson DG
Expert Opin Pharmacother; 1999 Nov; 1(1):121-35. PubMed ID: 11249555
[TBL] [Abstract][Full Text] [Related]
8. A 10-year perspective on donepezil.
Cheewakriengkrai L; Gauthier S
Expert Opin Pharmacother; 2013 Feb; 14(3):331-8. PubMed ID: 23316713
[TBL] [Abstract][Full Text] [Related]
9. Brain injury, cognitive impairment, and donepezil.
Whitlock JA
J Head Trauma Rehabil; 1999 Aug; 14(4):424-7. PubMed ID: 10407214
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial.
Black S; Román GC; Geldmacher DS; Salloway S; Hecker J; Burns A; Perdomo C; Kumar D; Pratt R;
Stroke; 2003 Oct; 34(10):2323-30. PubMed ID: 12970516
[TBL] [Abstract][Full Text] [Related]
11. Donepezil hydrochloride: a treatment drug for Alzheimer's disease.
Sugimoto H
Chem Rec; 2001; 1(1):63-73. PubMed ID: 11893059
[TBL] [Abstract][Full Text] [Related]
12. Donepezil: a review.
Seltzer B
Expert Opin Drug Metab Toxicol; 2005 Oct; 1(3):527-36. PubMed ID: 16863459
[TBL] [Abstract][Full Text] [Related]
13. Clinical benefits of a new piperidine-class AChE inhibitor.
Doody RS
Eur Neuropsychopharmacol; 1999 Apr; 9 Suppl 2():S69-77. PubMed ID: 10332937
[TBL] [Abstract][Full Text] [Related]
14. Vitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC; Thomas RG; Grundman M; Bennett D; Doody R; Ferris S; Galasko D; Jin S; Kaye J; Levey A; Pfeiffer E; Sano M; van Dyck CH; Thal LJ;
N Engl J Med; 2005 Jun; 352(23):2379-88. PubMed ID: 15829527
[TBL] [Abstract][Full Text] [Related]
15. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipid levels in Alzheimer's disease patients treated by Donepezil hydrochloride: a cross-sectional study.
Adunsky A; Chesnin V; Ravona R; Harats D; Davidson M
Arch Gerontol Geriatr; 2004; 38(1):61-8. PubMed ID: 14599705
[TBL] [Abstract][Full Text] [Related]
17. Donepezil for Alzheimer's disease in clinical practice--The DONALD Study. A multicenter 24-week clinical trial in Germany.
Froelich L; Gertz HJ; Heun R; Heuser I; Jendroska K; Kornhuber J; Kurz A; Mueller-Thomsen T; Ries F; Waechtler C; Metz M; Goebel C
Dement Geriatr Cogn Disord; 2004; 18(1):37-43. PubMed ID: 15084792
[TBL] [Abstract][Full Text] [Related]
18. The long-term efficacy and tolerability of donepezil in patients with vascular dementia.
Wilkinson D; Róman G; Salloway S; Hecker J; Boundy K; Kumar D; Posner H; Schindler R
Int J Geriatr Psychiatry; 2010 Mar; 25(3):305-13. PubMed ID: 19623601
[TBL] [Abstract][Full Text] [Related]
19. Neuroleptic malignant-like syndrome due to donepezil and maprotiline.
Ohkoshi N; Satoh D; Nishi M; Shoji S
Neurology; 2003 Mar; 60(6):1050-1. PubMed ID: 12654986
[No Abstract] [Full Text] [Related]
20. Feasibility of vascular dementia treatment with cholinesterase inhibitors.
Li Y; Meyer JS; Haque MA; Chowdhury MH; Hinh P; Quach M
Int J Geriatr Psychiatry; 2002 Feb; 17(2):194-6. PubMed ID: 11813286
[No Abstract] [Full Text] [Related]
[Next] [New Search]
